Nektar Therapeutics
NKTR
#5996
Rank
A$1.61 B
Marketcap
A$47.34
Share price
-3.03%
Change (1 day)
-49.10%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): A-$9.90

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$10.05. In 2025 the company made an earnings per share (EPS) of A-$15.30 a decrease over its 2024 EPS that were of A-$13.29.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$9.90-35.33%
2025A-$15.3015.12%
2024A-$13.29-59.54%
2023A-$32.85-25.89%
2022A-$44.33-31.12%
2021A-$64.3514.86%
2020A-$56.03-1.19%
2019A-$56.70-163.96%
2018A$88.66-725.4%
2017A-$14.18-42.73%
2016A-$24.7583.33%
2015A-$13.5039.53%
2014A-$9.68-69.29%
2013A-$31.50-6.67%
2012A-$33.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.02-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.07-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.07-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.12-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.49-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.68-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$0.90-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland